Salix Did Its Part In Developing Napo Drug, Atty Argues

Law360, New York (August 22, 2013, 6:50 PM EDT) -- Salix Pharmaceuticals Inc. took all reasonable best efforts to help Napo Pharmaceuticals Inc. develop an anti-diarrhea drug, Salix's attorney told a New York state judge during a hearing Thursday, arguing that it didn't have to develop the drug for other uses.

The drug is called crofelemer, a botanically derived anti-diarrhea medication, and the U.S. Food and Drug Administration eventually approved it for use with certain HIV/AIDS patients in 2012 after Napo brought Salix on board to revive its stalled efforts at developing the patented medication. ...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.